Sponsored by

Cleveland Clinic Brain Tumor and Neuro-Oncology Center

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 701 to 725 of about 5895

Previous 25

Website Changes

05/16/2021

GT Medical Technologies Announces First Patient Has Been Enrolled In Clinical Trial Evaluating GammaTile® Therapy In Patients With Metastatic Brain Tumors

05/11/2021

Tumor-treating fields (TTFields)-based cocktail therapy: a novel blueprint for glioblastoma treatment

05/11/2021

Foucused Ultrasound Webinar added to our video library!

05/09/2021

National Walks To End Brain Tumors

05/09/2021

Temozolomide chronotherapy in patients with glioblastoma: a retrospective single-institute study

05/09/2021

Focused Ultrasound Webinar Tonight! (Sunday 5/9/21)

05/09/2021

Focused Ultrasound Webinar now posted to website!

05/08/2021

Medicenna posts positive data from mid-stage brain cancer study

05/08/2021

Dabrafenib-trametinib combination active in BRAF V600E-mutant glioma

05/08/2021

Immunotherapy for hard-to-treat cancers ready to move toward clinical trials

05/06/2021

Brain Tumor Awareness Month Webinars continues this Sunday, May 9, 2021 with: Current Status and Future Directions of Focused Ultrasound for Brain Tumors

05/04/2021

The efficacy of dendritic cell vaccine for newly diagnosed glioblastoma: a meta-analysis of randomized controlled studies

05/02/2021

Brain Tumor Awareness Month Webinars Start tonight (Sunday May 2, 2021)!

04/29/2021

Brain Tumor Awareness Month Webinars!

04/29/2021

xCures launches xACCESS for Providers

04/25/2021

Curing Benign Paroxysmal Positional Vertigo in Patients With Brain Tumor: Case Series and Literature Review

04/23/2021

Musella Foundation Copay Program now closed to new and renewal patients

04/23/2021

10th Annual National Walk to End Brain Tumors and Silent Auction

04/22/2021

IQAI commits to Phase1 study for drug candidate in the treatment of Glioblastoma (GBM), a grade IV brain tumor

04/22/2021

Candel Therapeutics Completes Enrollment in Phase 1 Clinical Trial of CAN-2409 in Combination with Opdivo® (nivolumab) for the Treatment of High-Grade Gliomas

04/20/2021

Novel CAR-T shows ‘promising early signs of clinical efficacy’ for diffuse midline gliomas

04/19/2021

Modified RANO (mRANO), iRANO, and standard RANO response to convection-enhanced delivery of IL4R-targeted immunotoxin MDNA55 in recurrent glioblastoma

04/15/2021

Treovir’s Oncolytic Virus Product Extends Survival in Children With Brain Tumors

04/14/2021

Novocure Announces Update on Phase 3 Pivotal LUNAR Trial of Tumor Treating Fields in Non-Small Cell Lung Cancer

04/12/2021

Treovir Announces Positive Results of Phase 1 Study of G207 in Pediatric Patients with Recurrent High-Grade Glioma

Our privacy / cookie policy has changed.
Click HERE to read it!